Comparisons of Drug-Eluting Balloon versus Drug-Eluting Stent in the Treatment of Young Patients with Acute Myocardial Infarction

Comparisons of Drug-Eluting Balloon versus Drug-Eluting Stent in the Treatment of Young Patients with Acute Myocardial Infarction

Background: The incidence of acute myocardial infarction (AMI) in the younger population has been increasing gradually in recent years. The objective of the present study is to investigate the safety and effectiveness of drug-eluting balloons (DEBs) in young patients with AMI. Methods: All consecuti...

Full description

Bibliographic Details
Main Authors:	Yi-Xing Yang, Kui-Zheng He, Jiang-Yuan Li, Yuan Fu, Chuang Li, Xin-Ming Liu, Hong-Jiang Wang, Mu-Lei Chen, Pi-Xiong Su, Li Xu, Le-Feng Wang
Format:	Article
Language:	English
Published:	MDPI AG 2023-01-01
Series:	Journal of Cardiovascular Development and Disease
Subjects:	drug-eluting balloon acute myocardial infarction young patients
Online Access:	https://www.mdpi.com/2308-3425/10/1/29

Similar Items

Comparisons of drug-eluting balloon versus drug-eluting stent for the treatment of cancer patients presenting with acute myocardial infarction
by: Yi-Xing Yang, et al.
Published: (2023-09-01)

Comparison of clinical outcomes after drug-eluting balloon and drug-eluting stent use for in-stent restenosis related acute myocardial infarction: a retrospective study
by: Chih-Yuan Fang, et al.
Published: (2018-04-01)

Short Term Outcome of Drug Eluting Balloon for Percutaneous Coronary Intervention
by: Maida Anwar, et al.
Published: (2023-12-01)

Three-Year Clinical Outcomes With the Cilotax Dual Drug-Eluting Stent vs Everolimus-Eluting Stents in Patients With Acute Myocardial Infarction
by: HyeYon Yu, PhD, et al.
Published: (2024-05-01)

Outcome of Coronary Edge In-stent Restenosis Management by Restenting Versus Drug-Eluting Balloon
by: Yasser Gaber Metwally, et al.
Published: (2024-12-01)

Drug-Eluting Stents and Balloons—Materials, Structure Designs, and Coating Techniques: A Review
by: I. Rykowska, et al.
Published: (2020-10-01)

Safety and efficacy of the Essential Pro paclitaxel drug-eluting balloon for the treatment of coronary in-stent restenosis
by: Lucio Padilla, et al.
Published: (2024-08-01)

Drug-Eluting Balloon: An Overview of Clinical Evidences on Safety and Effectiveness
by: Khosro Keshavarz, et al.
Published: (2015-10-01)

Scoring balloon versus drug-eluting balloon in coronary intervention for very small coronary vessels
by: Yasser Gaber Metwally, et al.
Published: (2021-01-01)

Efficacy and safety of durable versus biodegradable polymer drug-eluting stents in patients with acute myocardial infarction complicated by cardiogenic shock
by: Woo Jin Jang, et al.
Published: (2024-03-01)

Drug‐Coated Balloons Versus Drug‐Eluting Stents or Plain Old Balloon Angioplasty: A Long‐Term in‐Stent Restenosis Study
by: Sacharias von Koch, et al.
Published: (2024-12-01)

A Multilayer Functionalized Drug-Eluting Balloon for Treatment of Coronary Artery Disease
by: Hak-Il Lee, et al.
Published: (2021-04-01)

Drug-coated balloon versus drug-eluting stent for femoropopliteal total occlusions: intraluminal versus subintimal approaches
by: Yong Hoon Kim, et al.
Published: (2024-09-01)

Research progress of drug eluting balloon in arterial circulatory system
by: Keji Lu, et al.
Published: (2024-03-01)

Drug-Coated Balloon vs. Drug-Eluting Stents for De Novo Unprotected Left Main Stem Disease: The SPARTAN-LMS Study
by: Tharusha D. Gunawardena, et al.
Published: (2023-02-01)

Structural and temporal dynamics analysis on drug-eluting stents: History, research hotspots and emerging trends
by: Lili Tan, et al.
Published: (2023-05-01)

The Endovascular Therapy for In-Stent Restenosis After Fluoropolymer-Based Drug-Eluting Stent Implantation in Femoropopliteal Lesions
by: Kazunori Horie, MD, et al.
Published: (2025-01-01)

Triple-vessel coronary artery aneurysms following drug-eluting stents
by: Immaneni Sathyamurthy, et al.
Published: (2023-01-01)

Drug-Coated Balloons versus Drug-Eluting Stents for the Treatment of De Novo Coronary Artery Disease: A Meta-Analysis of Randomized Controlled Trials
by: Jialong Niu, et al.
Published: (2024-12-01)

Drug-Eluting Stents: Technical and Clinical Progress
by: Maciej Koźlik, et al.
Published: (2023-02-01)

A Meta-Analysis of 3-Year Outcomes of Drug-Coated Balloons Versus Drug-Eluting Stents for Small-Vessel Coronary Artery Disease
by: Adelina Dobromir Angheluta, DEC, et al.
Published: (2024-10-01)

Clinical value of drug-coated balloon versus second-generation drug-eluting stent for de novo lesions in large coronary arteries: insights from the real world
by: Kang Zhao, et al.
Published: (2024-12-01)

Long-term Outcomes of Drug-eluting Stents in Symptomatic Intracranial Stenosis
by: Soonchan Park, et al.
Published: (2013-02-01)

Comparison of angiographic change in side-branch ostium after drug-coated balloon vs. drug-eluting stent vs. medication for the treatment of de novo coronary bifurcation lesions
by: Ae-Young Her, et al.
Published: (2024-05-01)

Risk assessment score for drug eluting stent restenosis
by: Z. A. Gabbasov, et al.
Published: (2018-09-01)

A Strategy for the In-Silico Assessment of Drug Eluting Stents: A Comparative Study for the Evaluation of Retinoic Acid as a Novel Drug Candidate for Drug Eluting Stents
by: Dimitrios S. Pleouras, et al.
Published: (2025-01-01)

Efficacy of Drug-Eluting Stents in Diabetic Patients Admitted with ST-Elevation Myocardial Infarctions Treated with Primary Percutaneous Coronary Intervention
by: Johannes Schmucker, et al.
Published: (2021-07-01)

Comparative efficacy and safety of drug-coated balloons versus drug-eluting stents in small vessel coronary artery disease: an updated systematic review and meta-analysis of randomized controlled trials
by: Monisha Augustine, et al.
Published: (2025-02-01)

The Diagnostic Value of Circulating Biomarkers and Role of Drug-Coated Balloons for In-Stent Restenosis in Patients with Peripheral Arterial Disease
by: Nunzio Montelione, et al.
Published: (2022-09-01)

A risk score for predicting in-stent restenosis in patients with premature acute myocardial infarction undergoing percutaneous coronary intervention with drug-eluting stent
by: Sen Liu, et al.
Published: (2024-07-01)

Laser Microperforation Assisted Drug-Elution from Biodegradable Films
by: Arkady S. Abdurashitov, et al.
Published: (2022-10-01)

Risk Factors and Incidence for In-Stent Restenosis with Drug-Eluting Stent: A Systematic Review and Meta-Analysis
by: Birong Liu, et al.
Published: (2024-12-01)

A bilayer swellable drug-eluting ureteric stent : localized drug delivery to treat urothelial diseases
by: Lim, Wei Shan, et al.
Published: (2019)

Efficacy and risks of drug-coated balloon treatment for coronary artery disease: A meta-analysis
by: Xinghua Bai, et al.
Published: (2023-11-01)

Impact of Insulin-Treated Compared to Non-Insulin-Treated Diabetes Mellitus on Outcome of Percutaneous Coronary Intervention with Drug-Coated Balloons versus Drug-Eluting Stents in De Novo Coronary Artery Disease: The Randomized BASKET-SMALL 2 Trial
by: Julia Seeger, et al.
Published: (2023-03-01)

High nitrogen stainless steel drug-eluting stent - Assessment of pharmacokinetics and preclinical safety in vivo
by: Shanshan Chen, et al.
Published: (2020-12-01)

Impact of Obstructive Sleep Apnea on In-Stent Restenosis in Coronary Heart Disease Patients after Elective Drug-Eluting Stenting
by: Wenjie Yang, et al.
Published: (2025-01-01)

Role of Lipid-Rich Plaques in Outcomes of Drug-Eluting Stent Implantation in Patients with Coronary Artery Disease
by: I. A. Mustafina, et al.
Published: (2019-03-01)

Longitudinal Stent Elongation: A Rare Complication of Third-Generation Drug-eluting Stent Platform
by: Dibya Kumar Baruah, et al.
Published: (2024-04-01)

Drug-eluting stents for coronary artery disease in the perspective of bibliometric analysis
by: Ying Zeng, et al.
Published: (2024-02-01)